SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Focused Visit (Follow-up) — Emile Griffith — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientEmile Griffith
Date of birth1938-02-03
IdentifiersMRN HR-BX005-SYN-TD; SSN (made up) 000-05-6418
Document date2005-09-15
AuthorCeleste Fairbanks-Ochieng, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Four-month review of PTSD, mood and memory. [S]

History of Present Illness

Emile Griffith returns with his care partner. He finished twelve sessions of cognitive processing therapy five weeks ago. He says he no longer blames himself in the same way: he went into the ring to win, not to hurt anyone, and he can now speak about his opponent without dreading the memory. Nightmares come about once a week. He takes sertraline 50 mg each morning without nausea, dizziness or bleeding. He completed ten sessions of physical therapy two weeks ago and does the home exercises most days; he has had no falls. His care partner notices no change in his memory. No thoughts of suicide. [S]

ElementDetail
PCL-526, from 41 at intake
PHQ-95; item 9 scored 0
Sodium137 mmol/L on sertraline 50 mg
NightmaresAbout once a week
Timed Up and Go10 seconds

Review of Systems

SystemResultFinding
PsychiatricPositiveNightmares about once a week; mood good; no thoughts of suicide
NeurologicalPositiveForgetfulness unchanged; no headaches, weakness or tremor
GastrointestinalNegativeNo nausea or diarrhea
MusculoskeletalNegativeNo falls; legs feel stronger

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Sertraline 25 mg oral tablet, one tablet each morningOne tablet each morningOral route2005-05-05 to 2005-06-16completedS
Sertraline 50 mg oral tablet, one tablet each morningOne tablet each morningOral route2005-06-16activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2005-09-15Body height170cmS
2005-09-15Body weight73.9kgS
2005-09-15Body mass index (BMI) [Ratio]25.6kg/m2S
2005-09-15Systolic blood pressure128mm[Hg]S
2005-09-15Diastolic blood pressure76mm[Hg]S
2005-09-15Heart rate66/minS
2005-09-15Respiratory rate14/minS
2005-09-15Body temperature36.7CelS
2005-09-15Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2005-09-15Sodium [Moles/volume] in Serum or Plasma137mmol/L135-145 mmol/LNormalS
2005-09-15Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]5{score}S
2005-09-15PTSD PCL-5 score [PCL-5]26{score}S

Physical Exam

Vital signs recorded on 2005-09-15; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 128/76 mmHg; pulse 66; weight 73.9 kg
MusculoskeletalTimed Up and Go 10 seconds; tandem walk without a side-step
Mental statusBright and relaxed; speaks about the fight calmly; no psychotic symptoms; denies thoughts of suicide

Problems

ProblemClinical statusVerificationCodeProvenance
Memory loss and confusion over about a year, worse in recent months, reported by him and his care partner: repeating stories and questions, losing the thread of conversations, mixing up days, two missed appointments, and once getting lost changing trains on a familiar route; cause to be foundresolvedconfirmed R41.3S — Synthetic presenting problem anchored to the documented short-term memory problems; resolved into the diagnosis at the third visit. Not a claim about his real symptoms at that age.
Post-traumatic stress disorder, chronic, after two index events (a title fight decades ago after which his opponent died, and a severe assault thirteen years ago): nightmares, unwanted images, avoidance of fight footage, guilt and self-blame, being on guard in crowds, poor sleep; PCL-5 41activeconfirmed F43.12S — Synthetic modern diagnosis at intake by clinical interview against DSM-5-TR criteria, anchored to his public words about lifelong nightmares; not a historical diagnosis.
Mild cognitive impairment (mild neurocognitive disorder) with slowed processing, executive and memory-retrieval deficits, most likely due to traumatic brain injury from a nineteen-year professional boxing career and a severe assault; meets the NINDS research criteria for traumatic encephalopathy syndrome (a research diagnosis); Alzheimer's disease co-pathology not excludedactiveconfirmed G31.84S — Synthetic modern diagnosis at the third visit after MRI and neuropsychological testing; anchored to the documented memory problems and pugilistic dementia, not a retrospective diagnosis of his real illness.
Personal history of traumatic brain injury: repetitive head impacts over 112 professional bouts, and a severe head injury in an assault thirteen years ago with months in hospitalactiveconfirmed Z87.820S — Synthetic coding of the documented career and assault.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyCognitive testing (MoCA)At diagnosis, then yearly, or sooner with changeUp to dateMoCA 22 at intake; no change reported; next at the yearly review
SurveyStaging (CDR) and function (ADL and IADL)At diagnosis, then yearlyUp to dateCDR 0.5 at two weeks; function unchanged
ExaminationMedicine review for anticholinergic, sedating and fall-risk drugs (Beers)Every visitCompleted todaySertraline 50 mg only
SurveyNeuropsychiatric symptom screen (apathy, irritability, paranoia, impulsivity)Every visitCompleted todayNo apathy, irritability, paranoia or impulsive behavior
SurveyPHQ-9 with suicide-risk review (item 9 and structured questions)Monthly during acute treatment; every visit during active treatmentCompleted todayPHQ-9 5, item 9 scored 0; no thoughts of suicide
SurveyPCL-5Baseline, then at each chronic-care visit during treatment; response judged after 8 to 12 weeksCompleted todayPCL-5 26: a clinically meaningful 15-point fall
Medication safetySertraline: nausea, sleep, falls, bleeding, and sodium (SSRIs can lower sodium in older adults)Two weeks after starting and after each dose change; sodium at those pointsDeferredDeviation: the sodium check ordered for two to four weeks after the increase to 50 mg was not done, because no visit fell then and the lab-only appointment was never scheduled. It was done today, three months after the increase: 137 mmol/L, normal, with no confusion, falls or other sign of low sodium, so no harm is known. Corrective action: a lab-only appointment is now booked automatically with any antidepressant start or dose change
ReferralTrauma-focused psychotherapy (cognitive processing therapy)Weekly, about twelve sessionsCompleted todayTwelve sessions completed five weeks ago
ExaminationFall risk (Timed Up and Go, gait and balance), STEADIAt diagnosis, yearly, and after any fallCompleted todayTimed Up and Go 10 seconds; no falls
ReferralPhysical therapy for balance and strengthOnce, after a Timed Up and Go above 12 secondsCompleted todayTen sessions completed two weeks ago; home program continues
Self-managementTravel, money and home safetyAt diagnosis and each follow-upCompleted todayNo episodes of getting lost; shared oversight of bills working
SurveyCare partner support and burden (Zarit Burden Interview, narrative)At diagnosis, then every 6 to 12 monthsUp to dateZarit 14 at the diagnosis visit; his care partner attends the caregiver class; next check at about six months
Self-managementAdvance care planningAt diagnosis; revisit yearly and at changesCompleted todayHealth care agent named and goals recorded at the annual wellness visit six weeks ago; reviewed today without change
ExaminationVascular risk factors (blood pressure, weight)Every visitCompleted todayBlood pressure 128/76 mmHg; weight 73.9 kg

Goal progress:

Guideline basis: Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for specialty care (2024); VA/DoD Clinical Practice Guideline for Management of Posttraumatic Stress Disorder and Acute Stress Disorder (2023); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, Non-Alzheimer's dementia and Depression/Bipolar/Mood Disorders monographs (2026); American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults (2023); STEADI (Stopping Elderly Accidents, Deaths and Injuries): Clinical Resources (2024)

Follow-up: Six-month review in six weeks with PCL-5 and PHQ-9, influenza vaccine and the second zoster dose. Call the clinic or 988 at any time if thoughts of suicide arise. Next scheduled visit 2005-10-27: six-month review: PTSD, mood, cognition, safety and the plan for the year ahead. [S]